- Home
- UEC vs KLTOW Comparison
UEC vs KLTOW Comparison
Compare UEC & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEC
- KLTOW
- Stock Information
- Founded
- UEC 2003
- KLTOW N/A
- Country
- UEC United States
- KLTOW United States
- Employees
- UEC N/A
- KLTOW 3
- Industry
- UEC Other Metals and Minerals
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UEC Basic Materials
- KLTOW Health Care
- Exchange
- UEC Nasdaq
- KLTOW Nasdaq
- Market Cap
- UEC 2.8B
- KLTOW N/A
- IPO Year
- UEC N/A
- KLTOW 2022
- Fundamental
- Price
- UEC $6.76
- KLTOW $0.26
- Analyst Decision
- UEC Strong Buy
- KLTOW
- Analyst Count
- UEC 3
- KLTOW 0
- Target Price
- UEC $10.08
- KLTOW N/A
- AVG Volume (30 Days)
- UEC 14.7M
- KLTOW N/A
- Earning Date
- UEC 06-02-2025
- KLTOW N/A
- Dividend Yield
- UEC N/A
- KLTOW N/A
- EPS Growth
- UEC N/A
- KLTOW N/A
- EPS
- UEC N/A
- KLTOW N/A
- Revenue
- UEC $66,837,000.00
- KLTOW N/A
- Revenue This Year
- UEC $41,201.79
- KLTOW N/A
- Revenue Next Year
- UEC $25.78
- KLTOW N/A
- P/E Ratio
- UEC N/A
- KLTOW N/A
- Revenue Growth
- UEC 70.62
- KLTOW N/A
- 52 Week Low
- UEC $3.85
- KLTOW N/A
- 52 Week High
- UEC $8.93
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- UEC 60.94
- KLTOW N/A
- Support Level
- UEC $6.33
- KLTOW N/A
- Resistance Level
- UEC $7.15
- KLTOW N/A
- Average True Range (ATR)
- UEC 0.38
- KLTOW 0.00
- MACD
- UEC 0.02
- KLTOW 0.00
- Stochastic Oscillator
- UEC 72.24
- KLTOW 0.00
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.